Opinion

Video

Evolving Commercialization and Distribution Models for PDTs

The panel discusses the challenges of delivering prescription digital therapeutics (PDTs) to patients, challenges caused by PDTs being considered behavioral health benefits, pharmacy benefits, medical benefits, and durable medical equipment benefits.

Related Videos
1 expert is featured in this series.
Dr Chun Chao
5 experts are featured in this series.
5 experts are featured in this series.
Frederick L. Locke, MD
2 experts in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo